The complexity of circulating HIV type 1 strains in Oyo State, Nigeria

AIDS Research and Human Retroviruses

Volumn 23, Issue 8, 2007, Pages 1020-1025

  Sankalé, Jean Louis ^a   Langevin, Stanley ^a   Odaibo, Georgina ^b   Meloni, Seema Thakore ^a   Ojesina, Akinyemi I ^a   Olaleye, David ^b   Kanki, Phyllis ^a,c  

^a Harvard AIDS Institute   (United States)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NIGERIA; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS TYPING;

GENES, ENV; GENES, GAG; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; NIGERIA; PHYLOGENY; PREVALENCE; RECOMBINATION, GENETIC;

EID: 34848864225     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0304     Document Type: Article

References (33)

1. McCutchan FE: Understanding the genetic diversity of HIV-1. AIDS 2000;14(Suppl. 3):S31-44
2. McCutchan FE, Carr JK, Bajani M, et al.: Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 1999;254:226-234
3. Renjifo B, Gilbert P, Chaplin B, et al.: Emerging recombinant human immunodeficiency viruses: Uneven representation of the envelope V3 region. AIDS 1999;13:1613-1621.
4. Kijak GH, Sanders-Buell E, Wolfe ND, et al.: Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa. AIDS Res Hum Retroviruses 2004;20:521-530.
5. Zolla-Pazner S, Gomy MK, and Nyambi PN: The implications of antigenic diversity for vaccine development. Immunol Lett 1999; 66:159-164.
6. van der Groen G, Nyambi PN, Beirnaert E, et al.: Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998;14(Suppl. 3): S211-221.
7. Gaschen B, Taylor J, Yusim K, et al.: Diversity considerations in HIV-1 vaccine selection. Science 2002;296:2354-2360.
8. Kaleebu P, French N, Mahe C, et al.: Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002;185:1244-1250.
9. Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, and Kaleebu P: The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort. AIDS Res Hum Retroviruses 2004;20:932-937.
10. Renjifo B, Fawzi W, Mwakagile D, et al.: Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol 2001;4:16-25.
11. Kanki PJ, Hamel DJ, Sankale JL, et al.: Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999;179:68-73
12. Laurent C, Bourgeois A, Faye MA, et al.: No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: A four-year prospective multicenter study. J Infect Dis 2002;186:486-492.
13. Neilson JR, John GC, Carr JK, et al.: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403.
14. Peeters M, Toure-Kane C, and Nkengasong JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17:2547-2560.
15. Montavon C, Toure-Kane C, Liegeois F, et al.: Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr 2000;23:363-374.
16. Nyambi P, Heyndrickx L, Vereecken K, et al.: Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. AIDS 2002;16:295-296.
17. Sankale JL, Hamel D, Woolsey A, et al.: Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997. J Hum Virol 2000;3:157-164.
18. Ellenberger DL, Pieniazek D, Nkengasong J, et al.: Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. AIDS Res Hum Retroviruses 1999;15:3-9.
19. Abimiku AG, Stern TL, Zwandor A, et al.: Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum Retroviruses 1994;10: 1581-1583.
20. Peeters M, Esu-Williams E, Vergne L, et al.: Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution. AIDS Res Hum Retroviruses 2000;16:315-325.
21. Agwale SM, Zeh C, Robbins KE, et al.: Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials. Vaccine 2002;20:2131-2139.
22. Howard TM, Olaleye DO, and Rasheed S: Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria. AIDS Res Hum Retroviruses 1994;10:1755-1757.
23. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The Clustal-X Windows interface - flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
24. Ojesina AI, Sankalé JL, Odaibo G, et al.: Subtype-specific patterns in HIV type 1 reverse transcriptase and protease in Oyo State, Nigeria: Implications for drug resistance and host response. AIDS Res Hum Retroviruses 2006;22:770-779.
25. Paraskevis D, Magiorkinis E, Magiorkinis G, et al.: Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. J Gen Virol 2001;82:2509-2514.
26. Sankalé JL, MBoup S, Essex M, and Kanki P: Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-2 and HIV-1 infected women. AIDS Res Hum Retroviruses 1998;14:1473-1481.
27. Sarr AD, Sankalé JL, Hamel DJ, et al.: Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype. Virology 2000;268:402-410.
28. Peeters M, Liegeois F, Torimiro N, et al.: Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient. J Virol 1999;73:7368-7375.
29. Takehisa J, Zekeng L, Ido E, et al.: Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-6820.
30. Tovanabutra S, Brodine SK, Mascola JR, et al.: Characterization of complete HIV type 1 genomes from non-B subtype infections in U.S. military personnel. AIDS Res Hum Retroviruses 2005;21: 424-429.
31. McCutchan FE, Sankalé JL, M'Boup S, et al.: HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res Hum Retroviruses 2004;20:819-826.
32. Burda ST, Konings FA, Williams CA, Anyangwe C, and Nyambi PN: HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common. AIDS Res Hum Retroviruses 2004;20: 1358-1363.
33. Toni T, Adje-Toure C, Vidal N, et al.: Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Cote d'Ivoire, West Africa. AIDS Res Hum Retroviruses 2005;21:667-672.